Beyond PSA: a need for additional markers for prostate cancer

Detection of Homologous Recombination Repair Gene Mutations by Tumor Tissue and Circulating Tumor DNA Testing in Prostate Cancer in the Phase III PROpel Trial.

JCO precision oncology·2026

LuRa: Efficacy and Safety of Radium-223 Following [177Lu]Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer.

Clinical genitourinary cancer·2026

Prognostic Value of Interim PSMA-PET Total Tumor Volume for Overall Survival Within ENZA-p, A Randomized Phase 2 Trial of Enzalutamide Versus Enzalutamide Plus [177Lu] Lu-PSMA-617 (ANZUP1901).

European urology·2026

Correlative Biomarker Analysis of PSMA Expression on CTCs and PSMA Imaging in a Phase I Study of PSMA-Targeted Tubulysin Conjugate EC1169.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Concepts in Phase 1 Radiopharmaceutical Therapy Trial Designs: Lessons from the SNMMI Dose Optimization in Radiopharmaceutical Therapy Development Workshop.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025

Docetaxel with Androgen Deprivation and Radiotherapy in High-risk Localized Prostate Cancer: An ICECaP Individual Patient Data Meta-analysis.

European urology oncology·2025

Orbital metastasis from prostate cancer: an atypical case of neuroendocrine dedifferentiation during progression from hormone-sensitive to refractory stage.

Clinical prostate cancer·2005

Recent trends in surgical treatment of localized prostate cancer.

Clinical prostate cancer·2005

Molecular effects of the isoflavonoid genistein in prostate cancer.

Clinical prostate cancer·2005

Prostate-specific membrane antigen vaccines: naked DNA and protein approaches.

Clinical prostate cancer·2005

Prior estrogen therapy as a predictor of response to subsequent estramustine-based chemotherapy in patients with androgen-independent prostate cancer.

Clinical prostate cancer·2005

Quantitative computed tomography perfusion of prostate cancer: correlation with whole-mount pathology.

Clinical prostate cancer·2005

A Novel 7 Sialylation-Related LncRNA Signature as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma.

Current medicinal chemistry·2026

Prediction of meningioma shrinkage after cyproterone acetate cessation.

Neuro-oncology advances·2026

Risk of colorectal cancer incidence and mortality after removals of polyps: a cohort study using the UK Biobank.

Annals of gastroenterology·2026

In vivo assessment of melanoma based on photoacoustic absorption and viscoelasticity imaging.

Biomedical optics express·2026

High-sensitivity Raman spectroscopy for prostate cancer detection and tissue extraction guidance.

Biomedical optics express·2026

Development and validation of a multimodal interpretable machine learning model for the identification of osteoporosis in patients with type 2 diabetes mellitus: a multicenter retrospective study.

Frontiers in endocrinology·2026

Related Experiment Videos

Beyond PSA: a need for additional markers for prostate cancer

Related Concept Videos

Detection of Homologous Recombination Repair Gene Mutations by Tumor Tissue and Circulating Tumor DNA Testing in Prostate Cancer in the Phase III PROpel Trial.

LuRa: Efficacy and Safety of Radium-223 Following [<sup>177</sup>Lu]Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer.

Prognostic Value of Interim PSMA-PET Total Tumor Volume for Overall Survival Within ENZA-p, A Randomized Phase 2 Trial of Enzalutamide Versus Enzalutamide Plus [<sup>177</sup>Lu] Lu-PSMA-617 (ANZUP1901).

Correlative Biomarker Analysis of PSMA Expression on CTCs and PSMA Imaging in a Phase I Study of PSMA-Targeted Tubulysin Conjugate EC1169.

Concepts in Phase 1 Radiopharmaceutical Therapy Trial Designs: Lessons from the SNMMI Dose Optimization in Radiopharmaceutical Therapy Development Workshop.

Docetaxel with Androgen Deprivation and Radiotherapy in High-risk Localized Prostate Cancer: An ICECaP Individual Patient Data Meta-analysis.

Orbital metastasis from prostate cancer: an atypical case of neuroendocrine dedifferentiation during progression from hormone-sensitive to refractory stage.

Recent trends in surgical treatment of localized prostate cancer.

Molecular effects of the isoflavonoid genistein in prostate cancer.

Prostate-specific membrane antigen vaccines: naked DNA and protein approaches.

Prior estrogen therapy as a predictor of response to subsequent estramustine-based chemotherapy in patients with androgen-independent prostate cancer.

Quantitative computed tomography perfusion of prostate cancer: correlation with whole-mount pathology.

A Novel 7 Sialylation-Related LncRNA Signature as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma.

Prediction of meningioma shrinkage after cyproterone acetate cessation.

Risk of colorectal cancer incidence and mortality after removals of polyps: a cohort study using the UK Biobank.

<i>In vivo</i> assessment of melanoma based on photoacoustic absorption and viscoelasticity imaging.

High-sensitivity Raman spectroscopy for prostate cancer detection and tissue extraction guidance.

Development and validation of a multimodal interpretable machine learning model for the identification of osteoporosis in patients with type 2 diabetes mellitus: a multicenter retrospective study.

Related Experiment Videos

Beyond PSA: a need for additional markers for prostate cancer

Related Concept Videos

Related Articles